SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2007-08-14
Filing Date Changed: 2007-08-14
Documents: 2
SEC Accession No.
0000812796-07-000066
Filing date: 2007-08-14
Accepted: 2007-08-14 14:03:39
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq Type Document Size Description
1 8-K pressrelease2q2007.htm 19917 2Q - 2007 PRESS RELEASE OF FINANCIAL RESULTS
2 EX-99.1 issuedpressrelease2q2007.htm 28346 PRESS RELEASE ISSUED FOR 2Q 2007
0000812796-07-000066.txt 49992 Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 071053623
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131
305-534-3383
 Mailing Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131